[go: up one dir, main page]

EP1248592A1 - Compositions deodorantes - Google Patents

Compositions deodorantes

Info

Publication number
EP1248592A1
EP1248592A1 EP01942543A EP01942543A EP1248592A1 EP 1248592 A1 EP1248592 A1 EP 1248592A1 EP 01942543 A EP01942543 A EP 01942543A EP 01942543 A EP01942543 A EP 01942543A EP 1248592 A1 EP1248592 A1 EP 1248592A1
Authority
EP
European Patent Office
Prior art keywords
acid
contain
carbon atoms
oil
preparations according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01942543A
Other languages
German (de)
English (en)
Inventor
Stefan BRÜNING
Helga Gondek
Achim Ansmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Personal Care and Nutrition GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7628360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1248592(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Priority to EP03007229A priority Critical patent/EP1338267B1/fr
Priority to EP03007228A priority patent/EP1338266B1/fr
Priority to EP03007230A priority patent/EP1338268B1/fr
Publication of EP1248592A1 publication Critical patent/EP1248592A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Definitions

  • the invention relates to deodorant preparations containing dial yl carbonates, antiperspirants, esterase inhibitors, bactericidal or bacteriostatic active substances and / or sweat-absorbing substances and their use for the production of deodorant preparations.
  • deodorants are used to remove unpleasant body odors.
  • Typical examples of such substances are aluminum compounds such as aluminum sulfate or aluminum chlorohydrate, zinc salts and citric acid compounds. Since the problem of odor inhibition is by no means completely solved, there is still a need for new preparations in which the deodorants can be easily emulsified and incorporated. This is to ensure a more homogeneous distribution of the deodorants and consequently an improvement in the effect, i.e. minimizing sweating and reducing odor. In addition, compared to the prior art, the skin feel when using such preparations should be improved and a higher stability of the end formulations should be achieved. The object of the invention was therefore to provide such products.
  • R 1 0 (CH 2 CH 2 0) nC (OCH 2 CH2) m-OR2 (I) in which R 1 is a linear alkyl and / or alkenyl radical having 6 to 22 carbon atoms, a 2-ethylhexyl, isotridecyl or isostearyl radical or a radical which is derived from a polyol having 2 to 15 carbon atoms and at least two hydroxyl groups, R 2 represents R 1 or an alkyl radical having 1 to 5 carbon atoms and n and m independently of one another represent 0 or numbers from 1 to 100,
  • Dialkyl carbonates which form component (a), are basically known substances, even if some of the claimed carbonates are described here for the first time.
  • the substances can be produced by transesterification of dimethyl or diethyl carbonate with the aforementioned hydroxy compounds using the methods of the prior art; an overview of this can be found, for example, in Chem.Rev. 96, 951 (1996).
  • Dialkyl carbonates of the formula (I) which are particularly suitable for solving the present task, meet one of the following conditions:
  • R represents a linear alkyl radical having 8 to 18 carbon atoms or a 2-ethylhexyl radical and R 2 represents R 1 or methyl;
  • Ri stands for a linear alkyl radical with 12 to 18 carbon atoms, R 2 for R 1 or methyl and n and m each for numbers from 1 to 10;
  • R 1 represents a polyol radical which is selected from the group formed by glycerol, alkylene glycols, technical oligoglycerol mixtures, methylol compounds, lower alkyl glucosides, sugar alcohols, sugars and amino sugars, and
  • R 2 is R 1 , a linear one or branched alkyl radical having 8 to 12 carbon atoms or methyl.
  • dialkyl carbonates of the two groups (A) and (B) are complete or partial transesterification products of dimethyl and / or diethyl carbonate with capron alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palm oleyl alcohol, , Isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, for example in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as a monomer fraction in the dimerization of unsaturated
  • transesterification products of the lower carbonates with the alcohols mentioned are likewise suitable in the form of their adducts with 1 to 100, preferably 2 to 50 and in particular 5 to 20 moles of ethylene oxide.
  • Di-n-octyl carbonates are preferred.
  • the carbonates of group (C) are described here for the first time. These are substances which are obtained by transesterifying dimethyl and / or diethyl carbonate in whole or in part with polyols. Polyols which are suitable for the purposes of the invention preferably have 2 to 15 carbon atoms and at least two hydroxyl groups. Typical examples are
  • Alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides especially those with 1 to 8 carbons in the alkyl radical such as methyl and butyl glucoside;
  • Sugar alcohols having 5 to 12 carbon atoms such as, for example, sorbitol or mannitol,
  • Aminosugars such as glucamine.
  • the agents according to the invention can contain the dialkyl carbonates in amounts of 1 to 80, preferably 5 to 50 and in particular 10 to 30% by weight, based on the solids content.
  • Antiperspirants of component (b1) are salts of aluminum, zirconium or zinc.
  • suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds e.g. B. with propylene glycol-1,2.
  • Aluminum chlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate and their complex compounds are preferably used.
  • conventional oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:
  • the agents according to the invention can contain the antiperspirants in amounts of 1 to 50, preferably 5 to 30 and in particular 10 to 25% by weight, based on the solids content.
  • esterase inhibitors of component (b2) preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT, Cognis GmbH, Dusseldorf / FRG).
  • the substances inhibit enzyme activity and thereby reduce odor.
  • esterase inhibitors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campeste bovine, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and esters thereof such as glutaric acid, monoethyl glutarate, diethyl glutarate, adipic acid, adipic remonoethylester, malonic acid and diethyl malonate, hydroxycarboxylic acids and esters thereof such as citric acid, malic acid, tartaric acid or Tartaric acid diethyl ester and zinc glycinate.
  • sterol sulfates or phosphates such as, for example, lanosterol, cholesterol, campeste bovine, stigmasterol and sitosterol sulfate or phosphate
  • dicarboxylic acids and esters thereof such as glutaric acid, monoethyl glutarate, diethyl glutarate,
  • the agents according to the invention can contain the esterase inhibitors in amounts of 0.01 to 20, preferably 0.1 to 10 and in particular 0.5 to 5% by weight, based on the solids content.
  • bactericidal or bacteriostatic active ingredients of component (b3) are in particular chitosan and phenoxyethanol.
  • 5-Chloro-2- (2,4-dichlorophenoxy) phenol which is sold under the Irgasan® brand by Ciba-Geigy, Basel / CH, has also proven to be particularly effective.
  • deodorants counteract, mask or eliminate body odors.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed.
  • deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers.
  • germ-inhibiting agents such as. B.
  • Suitable odor absorbers are substances that absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixators", such as, for example, the main component. B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, deodorants their respective Give fragrance.
  • Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • the ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones, for example, the jonones and methylcedryl ketone, and the alcohols Anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil.
  • the agents according to the invention can contain the bactericidal or bacteriostatic active ingredients in amounts of 0.01 to 5 and preferably 0.1 to 2% by weight, based on the solids content.
  • Starch such as Dry Flo Plus (from National Starch), silicates, talc and other substances similar
  • the agents according to the invention can contain the sweat-absorbing substances in amounts of 0.1 to 30, preferably 1 to 20 and in particular 5 to 10% by weight, based on the solids content.
  • Another object of the invention relates to the use of preparations from dialkyl carbonates, antiperspirants, UV light protection filters, esterase inhibitors, bactericidal or bacteriostatic active ingredients and / or sweat-absorbing substances for the production of deodorant preparations.
  • compositions can contain components (a) and (b) preferably in the following amounts, based on the solids content:
  • the active ingredients In order to be able to apply the active ingredients to the skin in a dosed, economical, convenient and cosmetically appealing way, they are usually incorporated into the basis of the formulation (for the usual ingredients see below).
  • the most important bases are: Alcoholic and aqueous / alcoholic solutions, emulsions, gels, oils, wax / fat masses, stick preparations and powder.
  • Other ingredients are superfatting agents, emulsifiers, antioxidants, as well as perfume oils, essential oils, dyes and - for spray applications - propellants such as propane and / or butane.
  • the agents are preferably sold as roller (roll-on emulsions), pens, deodorant or pump sprays.
  • agents can also contain, as further auxiliaries and additives, mild surfactants, pearlescent waxes, consistency agents, thickeners, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, additional deodorants, film formers, solubilizers, preservatives, dyes and the like.
  • mild surfactants pearlescent waxes, consistency agents, thickeners, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, additional deodorants, film formers, solubilizers, preservatives, dyes and the like.
  • Anionic, nonionic, cationic and / or amphoteric or amphoteric surfactants may be present as surface-active substances, the proportion of which in the compositions is usually about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight.
  • anionic surfactants are soaps, alkyl benzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ethersulfates, glycerin ether sulfates, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sulfate, fatty acid ether sul
  • anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosidic acid derivatives or glucoronic acid, or glucoronic acid , Protein hydrolysates (especially vegetable products based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • the surfactants mentioned are exclusively known compounds. With regard to the structure and manufacture of these substances, reference is made to relevant reviews, for example, J.Falbe (ed.), “Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, pp. 54-124 or J.Falbe (ed.), "Catalysts, Tenside und Mineralöladditive ", Thieme Verlag, Stuttgart, 1978, pp. 123-217.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether, Monogly- ceridsulfate, mono- and / or dialkyl sulfosuccinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, ethercarboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates , the latter preferably based on wheat proteins.
  • oil body preferably fatty alcohol polyglycol ether
  • Monogly- ceridsulfate mono- and / or dialkyl sulfosuccinates
  • fatty acid taurides fatty acid glutamates
  • ⁇ -olefin sulfonates ethercarboxylic acids
  • alkyl oligoglucosides fatty acid glucamides
  • esters of linear C ⁇ -C ⁇ fatty acids with branched alcohols in particular 2-ethylhexanol
  • esters of Ci8-C3 ⁇ -alkylhydroxycarboxylic acids with linear or branched C6-C 22 fatty alcohols cf.
  • Dioctyl malates esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C ⁇ -C-io fatty acids, liquid mono- / di- / triglyceride mixtures based on C ⁇ -Ci ⁇ -fatty acids, esters of C ⁇ -C ⁇ -fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C2-Ci2-dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, Guerbet carbonates, esters of benzoic acid with linear and / or branched C6-C22 alcohol
  • polyhydric alcohols such as
  • Finsolv® TN linear or branched, symmetrical or asymmetrical dialkyl ethers with 6 to 22 carbon atoms per alkyl group, ring opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicon methicone types etc.) and / or aliphatic or naphthenic hydrocarbons , such as squalane, squalene or dialkylcyclohexanes.
  • silicone oils cyclomethicones, silicon methicone types etc.
  • aliphatic or naphthenic hydrocarbons such as squalane, squalene or dialkylcyclohexanes.
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (e.g. cellulose) / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are homolog mixtures whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
  • Alkyl and / or alkenyl oligoglycosides their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to preferably about 8 are suitable.
  • the degree of oligomerization is a statistical mean value, one of which is customary for such technical products Is based on homolog distribution.
  • Typical examples of suitable partial glycerides are hydroxystearic rinTalkrediglycerid Hydroxystea-, isostearic acid, Isostearinklarediglycerid, oleic acid monoglyceride, oleic klarediglycerid, diglyceride Ricinolklamoglycerid, Ricinolklarediglycerid, Linolklaremonoglycerid, linoleic acid diglyceride, LinolenTalkremonoglycerid, Linolenchurediglycerid, Erucaklaklamonoglycerid, erucic acid, Weinchuremonoglycerid, Weinklarediglycerid, Citronenklamonoglycerid, Citronendiglyce- rid, malic acid monoglyceride, malic acid diglyceride and their technical mixtures, which may still contain minor amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably 5 to 10,
  • sorbitan sorbitan As sorbitan sorbitan, sorbitan sesquiisostearate, Sorbitan, sorbitan triisostearate, sorbitan monooleate, sorbitan, sorbitan, sorbitan come tanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, sorting bitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, sorbitan sesquihydroxystearat, Sorbitandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitansesq u itartrat, Sorbitanditartrat, Sorbitantritartrat, Sorbitanmonocitrat, Sorbitansesquicitrat, Sorbitandici
  • polyglycerol esters are polyglyceryl-2 dipolyhydroxystearates (Dehymuls® PGPH), polyglycerol-3-diisostearates (Lameform® TGI), polyglyceryl-4 isostearates (Isolan® Gl 34), polyglyceryl-3 oleates, diisostearoyl polyglyearylate-3 (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Gare® 450), Polyglyceryl-3 Beeswax (Gera Bellina®), Polyglyceryl-4 Caprate (Poiyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL) , Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimer
  • polystyrene resin examples include the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, taig fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N, N ⁇ dimethylammonium glycinate, for example coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylm -hydroxyethylimidazolines each with 8 to 18 carbon atoms in the alkyl or
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C ⁇ / i ⁇ alkyl or acyl group, contain at least one free amino group and at least one -COOH or -S0 3 H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and Ci2 / i8-acylsarcosine.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, i.e. Solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids, come as waxes, among others. natural waxes, e.g. Candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walnut, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, microfax waxes chemically modified waxes (hard waxes), e.g.
  • natural waxes e.g. Candelilla wax, carnauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax,
  • fat-like substances such as lecithins and phospholipids can also be used as additives.
  • lecithins as those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often referred to in the art as phosphatidylcholines (PC) and follow the general formula
  • R typically represents linear aliphatic hydrocarbon radicals with 15 to 17 carbon atoms and up to 4 cis double bonds.
  • lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats.
  • sphingosines or sphingolipids are also suitable.
  • Pearlescent waxes that can be used are, for example: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid, behenic acid or hydroxybehenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or poly
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates , (e.g.
  • surfactants such as, for example ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, e.g. a quaternized hydroxyethyl cellulose available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinyl pyrrolidone / vinyl imidazole polymers such as e.g.
  • Luviquat® condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, e.g. Amodimethicones, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides, e.g.
  • cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline, condensation products of dihaloalkylene, such as e.g. Dibromobutane with bisdialkylamines, e.g. Bis-dimethylamino-1,3-propane, cationic guar gum, e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternized ammonium salt polymers such as e.g. Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol.
  • dihaloalkylene such as e.g. Dibromobutane with bisdialkylamines, e.g. Bis-dimethylamino-1,3-propane
  • cationic guar gum e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese
  • quaternized ammonium salt polymers such as e.g
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinyl pyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isoboryl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and their esters, and non-crosslinked polyols crosslinked polyacrylic acids, acrylamidopropyl trimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert.Butylaminoethylmethacrylat / 2 Hydroxyproyl- methacrylate copolymers, polyvinylpyrrolidone, vinylpyrrolidone / vinyl acetate copolymers, vinylpyrrolidone / Dimethylaminoethylmethacrylat ⁇ inylcaprol
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • a detailed overview of suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976).
  • Biogenic active substances are, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, deoxyribonucleic acid, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts and vitamin complexes.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance. UV light protection filters and antioxidants
  • UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again.
  • UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate
  • Triazine derivatives such as 2.4 l of 6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyl triazone, as described in EP 0818450 A1 or Dioctyl butamido triazone (Uvasorb® HEB);
  • UV-A filters Derivatives of benzoylmethane, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione, 4-tert, are particularly suitable as typical UV-A filters.
  • the UV-A and UV-B filters can of course can also be used in mixtures.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm.
  • the pigments can also be surface-treated, ie hydrophilized or hydrophobized. Typical examples are coated titanium dioxides such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used. Further suitable UV light protection filters can be found in the overview by P.Finkel in S ⁇ FW Journal 122, 543 (1996) and Perfumery and Cosmetics 3 (1999), page 11ff.
  • secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine) , Carotenoids, carotenes (e.g.
  • ⁇ -carotene, ⁇ -carotene, lycopene and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propyithiouracil and other thiols (e.g.
  • thioredoxin glutathione, cysteine, Cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, pal itoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their Salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, Butioninsulfone, penta-, hexa- sulfin, heptathione) compatible doses (e.g.
  • (metal) chelators e.g. -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, Bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenylglycinate, allylcyclohexyl benzylatepylpropionate, allyl cyclohexyl propyl pionate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, ⁇ -isomethyl ionone and methyl cedryl ketone the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol
  • the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • compositions 1 to 4 are according to the invention, formulations V1 and V2 are used for comparison. The results are summarized in Table 3.
  • Table 3 Oil in water emulsions for roll-on and sprayable antiperspirant / deodorant applications Quantity in% by weight -

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Compositions déodorantes à renforcement synergique de la performance, qui contiennent (a) des carbonates de dialkyle, (b1) des anti-transpirants, (b2) des inhibiteurs d'estérase, (b3) des principes actifs bactéricides ou bactériostatiques et/ou (b4) des substances absorbant la transpiration.
EP01942543A 2000-01-21 2001-01-12 Compositions deodorantes Withdrawn EP1248592A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03007229A EP1338267B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007228A EP1338266B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007230A EP1338268B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10002643 2000-01-21
DE10002643A DE10002643A1 (de) 2000-01-21 2000-01-21 Desodorierende Zubereitungen
PCT/EP2001/000321 WO2001052806A1 (fr) 2000-01-21 2001-01-12 Compositions deodorantes

Related Child Applications (3)

Application Number Title Priority Date Filing Date
EP03007230A Division EP1338268B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007228A Division EP1338266B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007229A Division EP1338267B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes

Publications (1)

Publication Number Publication Date
EP1248592A1 true EP1248592A1 (fr) 2002-10-16

Family

ID=7628360

Family Applications (4)

Application Number Title Priority Date Filing Date
EP03007230A Revoked EP1338268B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP01942543A Withdrawn EP1248592A1 (fr) 2000-01-21 2001-01-12 Compositions deodorantes
EP03007228A Revoked EP1338266B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007229A Revoked EP1338267B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP03007230A Revoked EP1338268B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP03007228A Revoked EP1338266B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes
EP03007229A Revoked EP1338267B1 (fr) 2000-01-21 2001-01-12 Compositions désodorisantes

Country Status (6)

Country Link
US (2) US20030053970A1 (fr)
EP (4) EP1338268B1 (fr)
JP (1) JP4911851B2 (fr)
DE (4) DE10002643A1 (fr)
ES (3) ES2231742T3 (fr)
WO (1) WO2001052806A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10033022A1 (de) * 2000-07-07 2002-01-17 Cognis Deutschland Gmbh Aerosole
DE10133399A1 (de) * 2001-07-13 2003-01-23 Cognis Deutschland Gmbh Zusammensetzung auf Wachsbasis
DE10136483A1 (de) * 2001-07-27 2003-02-13 Cognis Deutschland Gmbh Emulgator Gemisch
US20030049218A1 (en) * 2001-08-28 2003-03-13 Amit Patel Antiperspirant deodorant emulsion
US20050255064A1 (en) * 2001-12-17 2005-11-17 Stefan Bruening Antiperspirant composition
DE10162049A1 (de) * 2001-12-17 2003-06-26 Cognis Deutschland Gmbh Antitranspirant-Zusammensetzung
US20060188551A1 (en) * 2003-01-08 2006-08-24 Matthias Hauser Products comprising a sheet and a wax dispersion
DE10323703A1 (de) * 2003-05-22 2004-12-23 Beiersdorf Ag Mikrobizide Zubereitungen und ihre Verwendung
DE10361528A1 (de) * 2003-12-23 2005-07-28 Beiersdorf Ag Wasserfreie und silikonölfreie Deodorant- oder Antitranspirantformulierung in Aerosolform
DE10361526A1 (de) * 2003-12-23 2005-07-28 Beiersdorf Ag Wasserfreie und silikonölfreie Deodorant- oder Antitranspirantformulierung in Stiftform
US20050238598A1 (en) * 2004-04-07 2005-10-27 Lionnel Aubert Antiperspirant compositions and method comprising wax microparticles
DE102004020647A1 (de) * 2004-04-22 2005-11-24 Coty B.V. Schweißabsorbierender Komplex für kosmetische Produkte
DE102004020646A1 (de) 2004-04-22 2005-11-24 Coty B.V. Schweißabsorbierender Komplex für kosmetische Produkte
GB0601644D0 (en) * 2006-01-27 2006-03-08 Unilever Plc Antiperspirant compositions
DE102006062433A1 (de) * 2006-12-27 2008-07-03 Henkel Kgaa Antitranspirant- und Deodorant-Zusammensetzungen mit verringertem Reizpotenzial
US8318806B2 (en) * 2007-10-03 2012-11-27 Zorbx Inc. Deodorizing composition and method of forming thereof
DE102008052747A1 (de) 2008-10-22 2010-04-29 Beiersdorf Ag Antitranspirantstift ohne flüchtige Trägeröle
ES2619319T3 (es) 2008-11-17 2017-06-26 L'oréal Método cosmético para tratar la transpiración humana usando partículas de un material mineral amorfo expandido; Composiciones
DE102009010665A1 (de) † 2009-02-27 2010-09-16 Beiersdorf Ag Verwendung von geladenen Tensiden zur Verminderung der Textilverfleckung durch Antitranspirantien
ES2543209T3 (es) * 2009-09-24 2015-08-17 Evonik Degussa Gmbh Polisiloxanos reticulados, proceso para su preparación y uso de los polisiloxanos reticulados en sistemas emulgentes para emulsiones de agua en aceite
EP2374835B1 (fr) 2010-04-07 2013-12-25 Evonik Degussa GmbH Poudre de polyamide 1010 et son utilisation dans des produits de soins personnels
WO2012064557A2 (fr) * 2010-11-08 2012-05-18 Lipo Chemicals Inc. Compositions déodorantes
JP5930647B2 (ja) * 2011-09-30 2016-06-08 株式会社マンダム 乳化型制汗化粧料
CA2882921C (fr) 2012-09-14 2017-10-24 The Procter & Gamble Company Compositions antitranspiration en aerosols, produits et procedes correspondants
EA032334B1 (ru) * 2014-03-12 2019-05-31 Басф Се Фунгицидный состав, содержащий алкоксилат, способ его изготовления, семена, его содержащие, способ борьбы с фитопатогенными грибами, применение алкоксилата для улучшения эффективности фунгицида и алкоксилат
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US20170173083A1 (en) * 2014-03-26 2017-06-22 The Brigham And Women's Hospital, Inc. Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells
DE102014221673A1 (de) 2014-10-24 2016-04-28 Henkel Ag & Co. Kgaa Chitosanhaltige schweißhemmende kosmetische Mittel, welche frei sind von Halogeniden und/oder Hydroxyhalogeniden von Aluminium und/oder Zirconium
DE102014222270A1 (de) * 2014-10-31 2016-05-04 Thomas Brunner Hygiene GmbH Kosmetische Antitranspirant-Zusammensetzung
US11708500B2 (en) 2017-10-02 2023-07-25 Tbf Environmental Technology Inc. Solvent compounds for use as coalescents
WO2020185654A1 (fr) 2019-03-08 2020-09-17 Colgate-Palmolive Company Compositions de soins personnels
US11331253B2 (en) * 2019-11-14 2022-05-17 Colgate-Palmolive Company Personal care compositions for treating odor causing bacteria and methods for the same
MX2024002382A (es) 2021-09-01 2024-03-14 Colgate Palmolive Co Composiciones para el cuidado personal que contienen mezclas posbioticas para reequilibrar el microbioma de la piel.
MX2024002455A (es) 2021-09-03 2024-03-08 Colgate Palmolive Co Composiciones para el cuidado personal.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239823A2 (fr) * 1999-12-24 2002-09-18 Cognis Deutschland GmbH & Co. KG Utilisation de desodorisants nanometriques

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2524110A1 (de) * 1974-06-12 1976-01-02 Colgate Palmolive Co Aerosol-antitranspirant
US5284649A (en) * 1992-09-29 1994-02-08 The Procter & Gamble Company Deodorant gel sticks containing 1-hydroxy pyridinethione active
US5830487A (en) 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
CA2177038A1 (fr) 1993-12-13 1995-06-22 Alrick Vincent Warner Composition de lotion conferant un toucher doux et legerement gras a du papier hygienique
CA2192177A1 (fr) 1994-06-17 1995-12-28 Thomas James Klofta Amelioration apportee a une composition de lotion destinee a traiter du papier de soie
AUPM632494A0 (en) 1994-06-21 1994-07-14 Biocom Pty Ltd Auxiliary injector
US5665426A (en) 1995-02-06 1997-09-09 Kimberly-Clark Corporation Soft treated tissue
DE19540296C2 (de) * 1995-10-28 1998-01-29 Henkel Kgaa Desodorierende Zubereitungen
JP2000512285A (ja) * 1996-06-12 2000-09-19 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 化粧品および／または薬剤製剤
NZ328102A (en) * 1996-06-24 1998-04-27 Givaudan Roure Int Fragrance precursors and deodorant compositions
DE19642874C1 (de) * 1996-10-17 1998-05-07 Henkel Kgaa Desodorierende Zubereitungen
US5968488A (en) * 1996-10-21 1999-10-19 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors
US5861147A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume
DE19737737C2 (de) * 1997-08-29 1999-09-23 Henkel Kgaa Verwendung von Dialkylcarbonaten
JPH11106326A (ja) 1997-09-30 1999-04-20 Nikko Chemical Co Ltd 炭酸ジエステルを含有する外用剤又は化粧料
DE19749819A1 (de) * 1997-11-11 1999-05-20 Henkel Kgaa Wäßrige kosmetische Zubereitungen in Stiftform
JPH11246378A (ja) * 1998-02-27 1999-09-14 Lion Corp 非水系粉末エアゾール型制汗剤組成物
JP4329914B2 (ja) * 1998-06-26 2009-09-09 三省製薬株式会社 制汗剤
JP2002527367A (ja) * 1998-10-14 2002-08-27 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ナノスケールのステロールおよびステロールエステルの使用
JP2002532403A (ja) * 1998-12-11 2002-10-02 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｕｖ光に対する保護を与えるナノスケール有機フィルターの使用
DE19858812A1 (de) * 1998-12-21 2000-06-29 Cognis Deutschland Gmbh Desodorierende kosmetische Mittel
DE19917743C2 (de) * 1999-04-20 2003-08-14 Biotec Asa Desodorierende Zubereitungen
US6153209A (en) 1999-09-28 2000-11-28 The Procter & Gamble Company Article having a transferable breathable skin care composition thereon
DE19962877A1 (de) * 1999-12-24 2001-06-28 Henkel Kgaa Haut- und Haarpflegemittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239823A2 (fr) * 1999-12-24 2002-09-18 Cognis Deutschland GmbH & Co. KG Utilisation de desodorisants nanometriques

Also Published As

Publication number Publication date
US20080317694A1 (en) 2008-12-25
EP1338266B1 (fr) 2004-11-03
US20030053970A1 (en) 2003-03-20
DE50104720D1 (de) 2005-01-05
DE50104789D1 (de) 2005-01-13
US8765104B2 (en) 2014-07-01
EP1338266A1 (fr) 2003-08-27
WO2001052806A1 (fr) 2001-07-26
ES2235123T3 (es) 2005-07-01
DE10002643A1 (de) 2001-07-26
EP1338268B1 (fr) 2004-12-01
JP2003525877A (ja) 2003-09-02
EP1338268A1 (fr) 2003-08-27
ES2233889T3 (es) 2005-06-16
JP4911851B2 (ja) 2012-04-04
DE50104433D1 (de) 2004-12-09
ES2231742T3 (es) 2005-05-16
EP1338267A1 (fr) 2003-08-27
EP1338267B1 (fr) 2004-12-08

Similar Documents

Publication Publication Date Title
EP1338267B1 (fr) Compositions désodorisantes
EP1458840A1 (fr) Concentres de lustre perlaire fluides a forte concentration
DE10034619A1 (de) Aniontensidfreie niedrigviskose Trübungsmittel
EP1456332A1 (fr) Concentres de lustre perlaire fluides a forte concentration
EP1286758A2 (fr) Agents emulsifiants
EP1200062A1 (fr) Dispersions aqueuses de lustre perlaire contenant des esters d'acide carboxylique alcoxylee
EP1235546A1 (fr) Utilisation de cires nanometriques
EP1189577A1 (fr) Emulsions cosmetiques
DE10021167A1 (de) Kosmetische Zubereitungen
WO2001010391A2 (fr) Utilisation d'esters d'acide carboxylique alcoxyles comme renforçateurs de mousses
DE19944545C1 (de) Wäßrige Perlglanzkonzentrate
EP1214043B1 (fr) Preparations cosmetiques ou pharmaceutiques
DE19950497B4 (de) Kosmetische und/oder pharmazeutische Zubereitungen und deren Verwendung
EP1235553B1 (fr) Preparations cosmetiques ou pharmaceutiques contenant des monoesters d'acide dicarboxylique
DE10319399A1 (de) Kosmetische und/oder pharmazeutische Zubereitungen
EP1060737B1 (fr) Concentrés aqueux nacrés
EP1061121B1 (fr) Concentré aqueux de lustre nacré
EP1309311A2 (fr) Preparations cosmetiques contenant des acides dicarboxyliques
EP1061122A1 (fr) Concentrés aqueux nacrés
DE19960099B4 (de) Guerbetalkohole
WO2001039734A1 (fr) Preparations cosmetiques et/ou pharmaceutiques contenant des acides amines et des composes d'azote organiques
DE19949281A1 (de) Verwendung von Emulgatormischungen
DE10055518A1 (de) Verwendung von amphoteren Tensiden
EP1231888A1 (fr) Utilisation de melanges d'agents de nettoyage comme agents emulsifiants pour la preparation d'agents demaquillants
DE19937297A1 (de) Kosmetische Zubereitungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20030610

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

RBV Designated contracting states (corrected)

Designated state(s): AT BE CH CY DE ES FR GB IT LI

18D Application deemed to be withdrawn

Effective date: 20031223